Cravatex Ltd Valuation
CRAVATEX · Services · Current price ₹422.8
Is Cravatex Ltd undervalued?
DocStoX estimates the fair value of Cravatex Ltd at ₹503 per share, versus the current market price of ₹423. That puts the stock about +18.9% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹428), Relative P/E (₹685), Graham floor (₹444). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹427 (bear) to ₹503 (base) to ₹685 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
Cravatex Ltd trades at a P/E of 22.6x and a P/B of 0.9x, with a dividend yield of 3.2%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on Cravatex Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.